H.C. Wainwright - Latest News, Analysis & Updates - Benzinga

SPY734.25+0.17%QQQ651.16+0.63%BTC/USD75,618.00−0.46%DIA513.35−0.18%GLD374.92−0.15%TLT81.84−0.11%

Premium Services

H.C. Wainwright

H.C. Wainwright is an investment bank and brokerage firm headquartered in the United States. The company provides capital markets services, equity research, and strategic advisory to emerging growth companies across sectors such as biotechnology, healthcare, and technology. Known for its analyst coverage and participation in public offerings, H.C. Wainwright plays a significant role in connecting growth-stage businesses with institutional and retail investors.

Oklo's New Reactor Milestone Lowers the Risk in Its Path to Approval

Oklo's New Reactor Milestone Lowers the Risk in Its Path to Approval

Uranium Energy Falls On Wider Loss, But Its Held-Back Inventory Could Mean Strong Margins Later

Uranium Energy Falls On Wider Loss, But Its Held-Back Inventory Could Mean Strong Margins Later

Oklo Ramps Up Spending As July 4 Deadline Looms: Is The Nuclear Startup Ready For Its Big Test?

Oklo Ramps Up Spending As July 4 Deadline Looms: Is The Nuclear Startup Ready For Its Big Test?

Uranium Energy Falls On Wider Loss, But Its Held-Back Inventory Could Mean Strong Margins Later

Uranium Energy Falls On Wider Loss, But Its Held-Back Inventory Could Mean Strong Margins Later

Oklo Ramps Up Spending As July 4 Deadline Looms: Is The Nuclear Startup Ready For Its Big Test?

Oklo Ramps Up Spending As July 4 Deadline Looms: Is The Nuclear Startup Ready For Its Big Test?

Uranium Energy Faces Revenue Dip But Stays Well-Funded For Growth: Analyst

Uranium Energy Faces Revenue Dip But Stays Well-Funded For Growth: Analyst

Biogen Posts Q4 Beat, Analysts Raise Price Targets On 'Significant Pipeline Diversification'

Biogen Posts Q4 Beat, Analysts Raise Price Targets On 'Significant Pipeline Diversification'

Uranium Energy Faces Revenue Dip But Stays Well-Funded For Growth: Analyst

Uranium Energy Faces Revenue Dip But Stays Well-Funded For Growth: Analyst

Biogen Posts Q4 Beat, Analysts Raise Price Targets On 'Significant Pipeline Diversification'

Biogen Posts Q4 Beat, Analysts Raise Price Targets On 'Significant Pipeline Diversification'

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat

Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat

HIVE Digital Technologies Posts Q2 Beat, Announces Plans To Expand AI Cloud Business

HIVE Digital Technologies Posts Q2 Beat, Announces Plans To Expand AI Cloud Business

H.C. Wainwright Recent News

Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application

Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application

FDA accepts NDA for Celcuity's advanced breast cancer therapy. Analyst downgrades stock due to high valuation. Next catalyst is topline data.

CoreWeave Stock Selloff An 'Over-Reaction,' Says Bullish Analyst

CoreWeave Stock Selloff An 'Over-Reaction,' Says Bullish Analyst

Analyst maintains Buy rating and $180 price target for CoreWeave despite market's reaction to Q3 earnings, citing strong prospects for AI.

Coinbase Jumps On Big Q3 Beat As Analysts Back 'Everything Exchange' Push

Coinbase Jumps On Big Q3 Beat As Analysts Back 'Everything Exchange' Push

Coinbase Global Inc's stock continued to rise after reporting upbeat Q3 results. Analysts maintain Buy ratings with price targets ranging from $399-$425.

Archer Aviation Q2 Disappoints: First Revenue Stream In Sight?

Archer Aviation Q2 Disappoints: First Revenue Stream In Sight?

Archer Aviation recorded gains in early trading on Tuesday, even after the company Monday reported downbeat second-quarter results.

CoreWeave's $9 Billion Bet Turns Crypto Miner Into AI Powerhouse

CoreWeave's $9 Billion Bet Turns Crypto Miner Into AI Powerhouse

CoreWeave Inc acquires Core Scientific Inc for $9 billion, with expected cost savings and transformation to direct ownership of HPC-grade capacity.

Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains

Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains

Telix Pharmaceuticals is advancing TLX592, which is designed for a faster elimination from circulation than standard antibodies.

Why Analysts Are Sweet On HIVE Digital Technologies Amid Mixed Q4 Signals

Why Analysts Are Sweet On HIVE Digital Technologies Amid Mixed Q4 Signals

HIVE Digital Technologies reported strong Q4 results amid exciting earnings season. Analysts maintained Buy rating and raised price targets.

CoreWeave IPO Was 'Fantastic Entry Point,' But Stock Now 'A Little Overheated'

CoreWeave IPO Was 'Fantastic Entry Point,' But Stock Now 'A Little Overheated'

CoreWeave has been one of the hottest IPOs in 2025 with shares up over 300% from their IPO price. An analyst says this is too big of an initial move.

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

Eton Pharma's Khindivi has won FDA approval as a pediatric adrenal insufficiency treatment. It is projected to surge in sales and launch in the U.S. in June 2025.

MARA Holdings' Q1 Results Fail To Excite, Yet Bitcoin Touching $103K Could Turn Losses To Gains

MARA Holdings' Q1 Results Fail To Excite, Yet Bitcoin Touching $103K Could Turn Losses To Gains

MARA Holdings Inc. reports Q1 results amid exciting earnings season. Key takeaways: HC Wainwright maintains Buy rating, Needham reiterates Hold.

Richtech Robotics: Transition To RaaS To Drive Accelerating Demand For Robotics, Says Bullish Analyst

Richtech Robotics: Transition To RaaS To Drive Accelerating Demand For Robotics, Says Bullish Analyst

Richtech Robotics (NASDAQ: RR) offers attractive opportunity to invest in rising demand for service robotics, according to analyst Scott Buck. Buy rating and $3.50 price target. RaaS model and improving financial performance make it a strong buy.

Rezolve AI Taps $5.5 Trillion Ecommerce Market With In-Store Style Shopping Experience, Analyst Says

Rezolve AI Taps $5.5 Trillion Ecommerce Market With In-Store Style Shopping Experience, Analyst Says

Rezolve AI (NASDAQ: RZLV) expected to see rapid revenue growth, analyst initiates coverage with Buy rating and $4 price target, citing potential in ecommerce market.

Belite Bio Analysts See Potential For Stock Gains With Progress In Key Trials

Belite Bio Analysts See Potential For Stock Gains With Progress In Key Trials

Belite Bio Inc (NASDAQ: BLTE) stock falls after reporting Q3 net loss of $36.1M; analysts maintain Buy/Overweight rating, citing positive trial results.

Inuvo Is Better Aligned With Consumer Demand For Privacy, New Regulations: Analyst

Inuvo Is Better Aligned With Consumer Demand For Privacy, New Regulations: Analyst

Inuvo is poised for significant revenue growth, according to analyst. AI and programmatic ads driving market.

This Mineral Mining Company Is Poised To Benefit From China Tensions: Analyst

This Mineral Mining Company Is Poised To Benefit From China Tensions: Analyst

Analyst initiates coverage of WWR with Buy rating and $2.50 PT. Westwater aims to create self-sustained graphite supply chain amid China's export regulations.

MARA Holdings Surges On Record Q4 Revenues, Analysts Weigh In

MARA Holdings Surges On Record Q4 Revenues, Analysts Weigh In

Shares of MARA Holdings (NASDAQ: MARA) climbed on Thurs. after reporting record Q4 revenues. The company increased its bitcoin holdings by more than 40%.

Coinbase Analysts See 'Inherent Profitability' In Q4 Results

Coinbase Analysts See 'Inherent Profitability' In Q4 Results

Shares of Coinbase Global Inc (NASDAQ: COIN) plunged despite upbeat Q4 revenues. Analysts maintain Buy/Nuetral ratings with price targets as high as $475.

Coinbase Q4 Earnings Preview: Trump Winning 2024 Election 'A Shot In The Arm For The Crypto Industry'

Coinbase Q4 Earnings Preview: Trump Winning 2024 Election 'A Shot In The Arm For The Crypto Industry'

Cryptocurrency company Coinbase Global (NASDAQ:COIN) could highlight record profitability and user metrics when the company reports fourth-quarter financial results after market close Thursday.

Bitcoin Miner CleanSpark Has 'Solid, Albeit Relatively Quiet' Quarter, Ready For Growth, Says Analyst

Bitcoin Miner CleanSpark Has 'Solid, Albeit Relatively Quiet' Quarter, Ready For Growth, Says Analyst

Shares of CleanSpark (CLSK) fell despite upbeat Q4 results. HC Wainwright analyst reiterated a Buy rating, while JPMorgan remains Neutral.

Plug Power Misses Q2 Revenues, Analysts Focus On Electrolyzer Deployments: 'The Bar Was Set Low'

Plug Power Misses Q2 Revenues, Analysts Focus On Electrolyzer Deployments: 'The Bar Was Set Low'

Shares of Plug Power tanked after the company reported a Q2 revenue miss. Analysts focus on Electrolyzer deployments.

These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers'

These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers'

Cara Therapeutics plans to explore strategic alternatives. There are no meaningful development programs in the pipeline, analysts note.

Coinbase Global Is 'Doing Almost Everything Right': 7 Analysts React To Q1 Results

Coinbase Global Is 'Doing Almost Everything Right': 7 Analysts React To Q1 Results

Coinbase reported Q1 adjusted earnings of $4.40 per share, significantly beating Street expectations as total revenues grew 112%

Coinbase Q1 Earnings Preview: What Analysts Are Saying, SEC Regulation & Other Items To Watch

Coinbase Q1 Earnings Preview: What Analysts Are Saying, SEC Regulation & Other Items To Watch

Cryptocurrency platform Coinbase Global (NASDAQ: COIN) is set to report first quarter financial results after market close Thursday. Here is a look at what analysts expect and what could be next for the company.